VitaNova Life Sciences Corporation (VNOV)

VitaNova Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 8, 2026	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022
Market Capitalization	20	12	5	15	18	3
Market Cap Growth	340.74%	155.56%	-70.00%	-14.80%	488.23%	-
Enterprise Value	19	10	4	14	18	3
Last Close Price	2.38	1.38	0.54	1.80	9.00	1.53

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 8, 2026	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022
PE Ratio	-	-	5.29	106.54	-	21.44
PS Ratio	6.12	3.80	1.69	26.30	463.52	24.95
PB Ratio	10.29	5.61	2.36	14.21	-297.45	-85.58
P/TBV Ratio	10.29	5.61	2.36	14.21	-	-
P/FCF Ratio	35.59	14.13	23.36	-	-	737.34
P/OCF Ratio	35.59	14.13	23.36	-	-	737.34

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 8, 2026	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022
EV/Sales Ratio	5.76	3.42	1.58	24.68	463.65	24.65
EV/EBIT Ratio	-	2870.53	3.48	68.50	-	-
EV/FCF Ratio	33.49	12.69	21.78	-	-	728.24

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 8, 2026	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022
Debt / Equity Ratio	-	-	-	0.00	-0.27	-0.35
Debt / FCF Ratio	-	-	-	-	-	2.98
Net Debt / Equity Ratio	-0.83	-0.78	-0.41	-0.56	-0.12	0.31
Net Debt / FCF Ratio	-2.88	-1.96	-4.06	1.57	-0.40	-2.71
Asset Turnover	1.45	1.29	1.54	0.95	2.39	-
Inventory Turnover	15.28	28.23	12.27	-	-	-
Quick Ratio	6.16	5.87	5.90	4.33	0.13	0.40
Current Ratio	7.13	6.14	6.49	8.71	0.13	0.40
Return on Equity (ROE)	-6.02%	-1.88%	57.39%	28.27%	-	-
Return on Assets (ROA)	-2.40%	0.10%	43.79%	21.39%	-95.14%	-
Return on Invested Capital (ROIC)	-22.17%	-2.58%	107.25%	69.24%	-	-
Return on Capital Employed (ROCE)	-4.50%	0.20%	63.30%	19.50%	40.90%	38.20%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 8, 2026	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022
Earnings Yield	-0.58%	-0.32%	18.90%	0.94%	-0.14%	4.67%
FCF Yield	2.81%	7.08%	4.28%	-2.50%	-0.10%	0.14%
Buyback Yield / Dilution	-	-	-135.00%	-81.28%	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 5, 2026

Data Sources Report a data error